247 related articles for article (PubMed ID: 18241249)
21. Multidrug resistance in a urothelial cancer cell line after 3, 1-hour exposures to mitomycin C.
Speers AG; Lwaleed BA; Featherstone JM; Cooper AJ
J Urol; 2007 Nov; 178(5):2171-5. PubMed ID: 17870115
[TBL] [Abstract][Full Text] [Related]
22. Antitumor effects of polyribonucleotides for mouse transitional cell carcinoma enhanced by cyclophosphamide.
Borden EC; Sidky YA; Groveman DS; Bryan GT
Cancer Res; 1985 Jan; 45(1):45-50. PubMed ID: 3965150
[TBL] [Abstract][Full Text] [Related]
23. Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth.
Jeong KC; Kim KT; Seo HH; Shin SP; Ahn KO; Ji MJ; Park WS; Kim IH; Lee SJ; Seo HK
J Urol; 2014 Feb; 191(2):510-8. PubMed ID: 23872029
[TBL] [Abstract][Full Text] [Related]
24. The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro.
Ebisuno S; Inagaki T; Kohjimoto Y; Ohkawa T
Cancer; 1997 Dec; 80(12):2263-7. PubMed ID: 9404703
[TBL] [Abstract][Full Text] [Related]
25. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
Yeh CW; Huang SS; Lee RP; Yung BY
Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
[TBL] [Abstract][Full Text] [Related]
26. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
Zhu CY; Li CY; Li Y; Zhan YQ; Li YH; Xu CW; Xu WX; Sun HB; Yang XM
Cell Death Differ; 2009 Mar; 16(3):395-405. PubMed ID: 19008924
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines.
Urech K; Buessing A; Thalmann G; Schaefermeyer H; Heusser P
Anticancer Res; 2006; 26(4B):3049-55. PubMed ID: 16886633
[TBL] [Abstract][Full Text] [Related]
28. Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer.
Pries R; Hogrefe L; Xie L; Frenzel H; Brocks C; Ditz C; Wollenberg B
Int J Mol Med; 2008 Feb; 21(2):209-15. PubMed ID: 18204787
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.
Kassouf W; Chintharlapalli S; Abdelrahim M; Nelkin G; Safe S; Kamat AM
Cancer Res; 2006 Jan; 66(1):412-8. PubMed ID: 16397256
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibitory effect of doxazosin on prostate and bladder cancer cells. Is the serotonin receptor pathway involved?
Siddiqui EJ; Shabbir M; Thompson CS; Mumtaz FH; Mikhailidis DP
Anticancer Res; 2005; 25(6B):4281-6. PubMed ID: 16309229
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
[TBL] [Abstract][Full Text] [Related]
32. Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer.
Watanabe R; Ohyama C; Aoki H; Takahashi T; Satoh M; Saito S; Hoshi S; Ishii A; Saito M; Arai Y
Cancer Res; 2002 Jul; 62(13):3850-4. PubMed ID: 12097299
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
34. Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro.
Zhang N; Sanders AJ; Ye L; Kynaston HG; Jiang WG
Anticancer Res; 2010 Jan; 30(1):87-95. PubMed ID: 20150621
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-143 as a tumor suppressor for bladder cancer.
Lin T; Dong W; Huang J; Pan Q; Fan X; Zhang C; Huang L
J Urol; 2009 Mar; 181(3):1372-80. PubMed ID: 19157460
[TBL] [Abstract][Full Text] [Related]
36. [Whole-body fluorescent imaging of the growth and metastasis of GFP-expressing bladder tumors].
Wu YD; Tan WL; Xie Y; Yu ZC; Zhao GZ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):436-40. PubMed ID: 16624746
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of interleukin-12 against murine bladder cancer.
Eto M; Harada M; Tamada K; Tokuda N; Koikawa Y; Nakamura M; Nomoto K; Naito S
J Urol; 2000 May; 163(5):1549-52. PubMed ID: 10751886
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
Hadaschik BA; ter Borg MG; Jackson J; Sowery RD; So AI; Burt HM; Gleave ME
BJU Int; 2008 Jun; 101(11):1347-55. PubMed ID: 18384637
[TBL] [Abstract][Full Text] [Related]
39. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI
Clin Cancer Res; 2008 Mar; 14(5):1510-8. PubMed ID: 18316576
[TBL] [Abstract][Full Text] [Related]
40. [Study on the inducible expression of toll-like receptors in human bladder cell line].
Li X; Gong ZY; Shi M; Wei Q; Li H; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):340-2. PubMed ID: 15181830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
